Evidence map›Paper›PMID 42162401›Full record

ArticleJournal of human hypertension2026

Blood pressure patterns and cardio-renal complications in primary aldosteronism compared with essential hypertension in a tunisian population.

Meriem Yazidi, Melika Chihaoui, Elyes Kamoun, Chayma Bel Hadj Sliman, Ibtissem Oueslati, Fatma Chaker, Nadia Khessairi

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Journal of human hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Meriem YazidiUniversity of Tunis el manar, Faculty of medicine of Tunis, La Rabta Hospital, Department of Endocrinology, Tunis, Tunisia. meriem.yazidi@fmt.utm.tn.ORCID http://orcid.org/0000-0002-4239-5229
Melika ChihaouiUniversity of Tunis el manar, Faculty of medicine of Tunis, La Rabta Hospital, Department of Endocrinology, Tunis, Tunisia.
Elyes KamounUniversity of Tunis el manar, Faculty of medicine of Tunis, La Rabta Hospital, Department of Endocrinology, Tunis, Tunisia.
Chayma Bel Hadj SlimanUniversity of Tunis el manar, Faculty of medicine of Tunis, La Rabta Hospital, Department of Endocrinology, Tunis, Tunisia.
Ibtissem OueslatiUniversity of Tunis el manar, Faculty of medicine of Tunis, La Rabta Hospital, Department of Endocrinology, Tunis, Tunisia.
Fatma ChakerUniversity of Tunis el manar, Faculty of medicine of Tunis, La Rabta Hospital, Department of Endocrinology, Tunis, Tunisia.
Nadia KhessairiUniversity of Tunis el manar, Faculty of medicine of Tunis, La Rabta Hospital, Department of Endocrinology, Tunis, Tunisia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary aldosteronism (PA) is a major cause of secondary hypertension associated with increased target organ damage beyond the effects of blood pressure (BP). This study aimed to compare BP characteristics and cardio-renal complications between patients with PA and essential hypertension (EH) in a Tunisian population. We conducted a retrospective study of 227 hospitalized patients (112 with PA and 115 with EH) at a tertiary care center between 2003 and 2023. Clinical, biological, and cardiovascular data were analyzed. Multivariate regression analysis was used to identify independent factors associated with target organ damage, which were more prevalent in PA. Patients with PA had longer hypertension duration, higher systolic and diastolic BP levels, and a higher prevalence of resistant hypertension. Chronic kidney disease (CKD) and left ventricular hypertrophy (LVH) were significantly more frequent in patients with PA (28.7 vs 14.4%; p = 0.01 and 47.4 vs 16.7%; p < 0.001, respectively). After multivariable adjustment, PA remained independently associated with LVH (aOR= 3.1; 95% CI [1.2-7.9]; p = 0.02), whereas its association with CKD was attenuated (p = 0.06; aOR: 2.0 [1.0-4.2]). Baseline aldosterone showed good discriminative ability for LVH (AUC = 0.715; 95% CI: [0.627-0.803]; p < 0.001), with an optimal cut-off value of 135.7 pg/mL. In conclusion, PA was associated with more severe hypertension and a markedly increased risk of LVH compared with EH, supporting a direct deleterious cardiac effect of aldosterone excess and underscoring the importance of early diagnosis and targeted treatment.

Indexed as

Blood PressureEssential HypertensionHyperaldosteronismHypertrophy, Left VentricularRenal Insufficiency, ChronicAdultAgedAldosteroneFemaleHumansMaleMiddle AgedPrevalenceRetrospective StudiesRisk FactorsTunisiaAldosterone

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.